Cargando…
Viscosupplementation for Osteoarthritis of the Knee: A Key Opinion Leader Panel Discussion
With a sharp rise in the prevalence of osteoarthritis of the knee (OAK) in a younger population, new management strategies are needed to preserve mobility, improve patients' quality of life, and reduce the effects of potential disease-related comorbidities. Viscosupplementation with the use of...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10408395/ https://www.ncbi.nlm.nih.gov/pubmed/29851537 http://dx.doi.org/10.18553/jmcp.2018.24.6-a.s2 |
_version_ | 1785086176115294208 |
---|---|
author | Bert, Jack Kenney, Jim Sgaglione, Nicholas A. McClelland, Scott Brophy, Robert Toth, John Ruane, Joseph Ali, Yousaf Arquette, Sheila Dasa, Vinod Lopes, Maria |
author_facet | Bert, Jack Kenney, Jim Sgaglione, Nicholas A. McClelland, Scott Brophy, Robert Toth, John Ruane, Joseph Ali, Yousaf Arquette, Sheila Dasa, Vinod Lopes, Maria |
author_sort | Bert, Jack |
collection | PubMed |
description | With a sharp rise in the prevalence of osteoarthritis of the knee (OAK) in a younger population, new management strategies are needed to preserve mobility, improve patients' quality of life, and reduce the effects of potential disease-related comorbidities. Viscosupplementation with the use of hyaluronic acid (HA) injection is a treatment option for OAK that can provide lubrication and elastic shock absorption, leading to potential pain relief, improved function, and reduced stiffness. A key opinion leader (KOL) panel discussion was held December 3, 2016, with the objective of sharing opinions, ideas, information, and trends regarding OAK and the potential treatment and management offered by viscosupplementation. The panel concluded that viscosupplementation with HA injections presents a viable, cost-effective, and safe alternative for the treatment of OAK. |
format | Online Article Text |
id | pubmed-10408395 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Academy of Managed Care Pharmacy |
record_format | MEDLINE/PubMed |
spelling | pubmed-104083952023-08-09 Viscosupplementation for Osteoarthritis of the Knee: A Key Opinion Leader Panel Discussion Bert, Jack Kenney, Jim Sgaglione, Nicholas A. McClelland, Scott Brophy, Robert Toth, John Ruane, Joseph Ali, Yousaf Arquette, Sheila Dasa, Vinod Lopes, Maria J Manag Care Spec Pharm Supplement With a sharp rise in the prevalence of osteoarthritis of the knee (OAK) in a younger population, new management strategies are needed to preserve mobility, improve patients' quality of life, and reduce the effects of potential disease-related comorbidities. Viscosupplementation with the use of hyaluronic acid (HA) injection is a treatment option for OAK that can provide lubrication and elastic shock absorption, leading to potential pain relief, improved function, and reduced stiffness. A key opinion leader (KOL) panel discussion was held December 3, 2016, with the objective of sharing opinions, ideas, information, and trends regarding OAK and the potential treatment and management offered by viscosupplementation. The panel concluded that viscosupplementation with HA injections presents a viable, cost-effective, and safe alternative for the treatment of OAK. Academy of Managed Care Pharmacy 2018-06 /pmc/articles/PMC10408395/ /pubmed/29851537 http://dx.doi.org/10.18553/jmcp.2018.24.6-a.s2 Text en Copyright © 2018, Academy of Managed Care Pharmacy. All rights reserved. https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits unrestricted use and redistribution provided that the original author and source are credited. |
spellingShingle | Supplement Bert, Jack Kenney, Jim Sgaglione, Nicholas A. McClelland, Scott Brophy, Robert Toth, John Ruane, Joseph Ali, Yousaf Arquette, Sheila Dasa, Vinod Lopes, Maria Viscosupplementation for Osteoarthritis of the Knee: A Key Opinion Leader Panel Discussion |
title | Viscosupplementation for Osteoarthritis of the Knee: A Key Opinion Leader Panel Discussion |
title_full | Viscosupplementation for Osteoarthritis of the Knee: A Key Opinion Leader Panel Discussion |
title_fullStr | Viscosupplementation for Osteoarthritis of the Knee: A Key Opinion Leader Panel Discussion |
title_full_unstemmed | Viscosupplementation for Osteoarthritis of the Knee: A Key Opinion Leader Panel Discussion |
title_short | Viscosupplementation for Osteoarthritis of the Knee: A Key Opinion Leader Panel Discussion |
title_sort | viscosupplementation for osteoarthritis of the knee: a key opinion leader panel discussion |
topic | Supplement |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10408395/ https://www.ncbi.nlm.nih.gov/pubmed/29851537 http://dx.doi.org/10.18553/jmcp.2018.24.6-a.s2 |
work_keys_str_mv | AT bertjack viscosupplementationforosteoarthritisofthekneeakeyopinionleaderpaneldiscussion AT kenneyjim viscosupplementationforosteoarthritisofthekneeakeyopinionleaderpaneldiscussion AT sgaglionenicholasa viscosupplementationforosteoarthritisofthekneeakeyopinionleaderpaneldiscussion AT mcclellandscott viscosupplementationforosteoarthritisofthekneeakeyopinionleaderpaneldiscussion AT brophyrobert viscosupplementationforosteoarthritisofthekneeakeyopinionleaderpaneldiscussion AT tothjohn viscosupplementationforosteoarthritisofthekneeakeyopinionleaderpaneldiscussion AT ruanejoseph viscosupplementationforosteoarthritisofthekneeakeyopinionleaderpaneldiscussion AT aliyousaf viscosupplementationforosteoarthritisofthekneeakeyopinionleaderpaneldiscussion AT arquettesheila viscosupplementationforosteoarthritisofthekneeakeyopinionleaderpaneldiscussion AT dasavinod viscosupplementationforosteoarthritisofthekneeakeyopinionleaderpaneldiscussion AT lopesmaria viscosupplementationforosteoarthritisofthekneeakeyopinionleaderpaneldiscussion |